These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Excretion product of D-860]. WITTENHAGEN G; MOHNIKE G Dtsch Med Wochenschr; 1956 Jun; 81(22):887-8. PubMed ID: 13344015 [No Abstract] [Full Text] [Related]
26. [THE INFLUENCE OF THE URINE PH ON THE ELIMINATION OF VARIOUS ACETYLATED SULFONAMIDES]. BRAUN W; ADLUNG J; MALORNY G Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Oct; 249():185-90. PubMed ID: 14347834 [No Abstract] [Full Text] [Related]
27. [Excretion and dilution of sulfonamides by tears]. BALIK J; URBANOVA S Sb Lek; 1959 Jul; 61():248-52. PubMed ID: 13796193 [No Abstract] [Full Text] [Related]
29. [CERTAIN MICROBIOLOGICAL PECULIARITIES OF NEW SULFANILAMIDES]. KUTZSCHE A Chemotherapia (Basel); 1964; 64():53-62. PubMed ID: 14178045 [No Abstract] [Full Text] [Related]
30. Pharmacological studies with sulfadimethoxine. BAGDON RE; RANDALL LO; LEFF WA Ann N Y Acad Sci; 1959 Sep; 82():3-9. PubMed ID: 13795735 [No Abstract] [Full Text] [Related]
31. Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations. Tuomisto J; Saris NE Ann Med Exp Biol Fenn; 1970; 48(1):38-48. PubMed ID: 5419724 [No Abstract] [Full Text] [Related]
32. [Behavior of sulfanilamides in the body]. Reimerdes E; Thumim JH Arzneimittelforschung; 1970 Sep; 20(9):1171-9. PubMed ID: 4922318 [No Abstract] [Full Text] [Related]
33. Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine. Vree TB; Hekster YA; Tijhuis MW; Baakman M; Oosterbaan MJ; Termond EF Pharm Weekbl Sci; 1984 Aug; 6(4):150-6. PubMed ID: 6483571 [TBL] [Abstract][Full Text] [Related]
35. PREVENTIVE EFFECTS OF PYRIMETHAMINE AND SOME SULFONAMIDES ON LEUCOCYTOZOON CAULLERYI IN CHICKENS. AKIBA K; EBISAWA S; NOZAWA S; KOMIYAMA T; MINAI T Natl Inst Anim Health Q (Tokyo); 1964; 4():222-8. PubMed ID: 14251571 [No Abstract] [Full Text] [Related]
36. SERUM CONCENTRATION AND ANTIBACTERIAL ACTIVITY OF 4-SULFANILAMIDO-5,6DIMETHOXYPYRIMIDINE. MADSEN ST Am J Med Sci; 1964 Feb; 247():217-22. PubMed ID: 14124711 [No Abstract] [Full Text] [Related]
37. [Clinical experiences with sulfadimethoxine]. QUATTRIN N; BRANCACCIO A; DINI E Gazz Med Ital; 1960 Jan; 119():8-11. PubMed ID: 14435481 [No Abstract] [Full Text] [Related]
38. [Blood and bone marrow changes following the use of sulfadimethoxine (Madribon)]. DUNNING AJ Ned Tijdschr Geneeskd; 1962 Aug; 106():1729-30. PubMed ID: 13888526 [No Abstract] [Full Text] [Related]
39. The comparative effect of various alkalis and urea upon the blood concentration, excretion, and conjugation of sulfonamides with glucuronic and acetic acid. ROHR JH; FREEMAN S Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():69. PubMed ID: 20341013 [No Abstract] [Full Text] [Related]
40. Kinetics of sulfamethylthiadiazole acetylation and excretion in humans. NELSON E; O'REILLY I J Pharm Sci; 1961 May; 50():417-20. PubMed ID: 13728275 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]